HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lars Jacobsson Selected Research

Astatine-211

7/2022Estimating the risk for secondary cancer following targeted alpha therapy with astatine-211 intraperitoneal radioimmunotherapy.
1/2021Evaluation of therapeutic efficacy of 211At-labeled farletuzumab in an intraperitoneal mouse model of disseminated ovarian cancer.
10/2007Therapeutic efficacy of astatine-211-labeled trastuzumab on radioresistant SKOV-3 tumors in nude mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lars Jacobsson Research Topics

Disease

23Neoplasms (Cancer)
07/2022 - 05/2002
16Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 09/2003
5Ascites
12/2017 - 11/2005
3Carcinoma (Carcinomatosis)
08/2013 - 10/2007
2Ovarian Epithelial Carcinoma
07/2022 - 01/2019
2Neoplasm Micrometastasis
08/2013 - 09/2003
2Schizophrenia (Dementia Praecox)
06/2013 - 04/2012
1Fatigue
01/2019
1Intestinal Perforation
01/2019
1Body Weight (Weight, Body)
12/2017
1Residual Neoplasm
11/2015
1Tardive Dyskinesia
02/2015
1Disease Progression
03/2013

Drug/Important Bio-Agent (IBA)

9Monoclonal AntibodiesIBA
01/2019 - 03/2003
6211At-labeled monoclonal antibody MX35IBA
01/2021 - 08/2006
4Biological ProductsIBA
08/2013 - 03/2003
3Astatine-211IBA
07/2022 - 10/2007
3AntibodiesIBA
01/2021 - 09/2003
3Radioisotopes (Radionuclides)IBA
01/2018 - 06/2003
3Antipsychotic Agents (Antipsychotics)IBA
02/2015 - 04/2012
2EpitopesIBA
01/2015 - 09/2003
2Immunoconjugates (Immunoconjugate)IBA
08/2013 - 12/2005
2Lysine (L-Lysine)FDA Link
12/2011 - 05/2002
2AstatineIBA
12/2009 - 09/2003
1Contrast MediaIBA
07/2022
1Colloids (Colloid)IBA
07/2022
1Thorium Dioxide (Thorotrast)IBA
07/2022
1farletuzumabIBA
01/2021
1Rituximab (Mabthera)FDA Link
01/2021
1AntigensIBA
01/2019
1Neoplasm Antigens (Tumor Antigens)IBA
01/2015
1Hematoxylin (Haematoxylon)IBA
08/2013
1Eosine Yellowish-(YS) (Eosin)IBA
08/2013
1procaine isothiocyanate (PRIT)IBA
03/2013
1AvidinIBA
12/2011
1Dihydrotachysterol (AT 10)IBA
10/2010
1Trastuzumab (Herceptin)FDA Link
10/2007
1poly-d-lysineIBA
09/2003
1Biotin (Vitamin H)FDA Link
09/2003
1SuspensionsIBA
03/2003

Therapy/Procedure

13Radioimmunotherapy
07/2022 - 09/2003
12Therapeutics
07/2022 - 05/2002
4Drug Therapy (Chemotherapy)
07/2022 - 07/2009
4Aftercare (After-Treatment)
12/2017 - 11/2005
2Catheters
01/2019 - 07/2009
1Intravenous Injections
01/2021
1Transcutaneous Electric Nerve Stimulation (TENS)
08/2013
1Radiotherapy
10/2010